RO-239424

N/A

Report date: 2026/03/04 20:01:44

NME

Base Information

Drug NameRO-239424

Drug Alias NameRo-239424/001RO-239424Ro-23-9424

ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibioticsSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibiotics

Mechanisms of ActionTopoisomerase IV inhibitorsBacterial DNA gyrase inhibitors

TargetsTopoisomerase IVBacterial DNA gyrase

Therapy Area/IndicationsBacterial Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesF. Hoffmann-La Roche Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesF. Hoffmann-La Roche Ltd

Active IndicationsN/A

Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A